Page results
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
3000 participants have been recruited to a clinical trial led by UCL and UCLH aimed at reducing the number of patients with breast cancer who are given chemotherapy unnecessarily.
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
-
As photographer Tom Pilston searched for a way to make his contribution during the Covid-19 pandemic, he cast around for a project which would allow him to pay tribute to the NHS he describes as "all that is good about the UK ... humane and caring, hard-working, sensitive and strong".
-
Mark Emberton joined the board as a non-executive director on 1 September 2022. He is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London.
-
UCLH is committed to not only treat patients’ illnesses but to provide an environment and an experience which contributes to patients’ general wellbeing.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
The stroke team at the National Hospital for Neurology and Neurosurgery (NHNN) is the first in the NHS to carry out implants on cryptogenic stroke patients rather than refer them to a cardiology service.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
Nailesh Rambhai became an associate non-executive director at UCLH in April 2022. A lawyer by background, he has also acted as group counsel and company secretary to a number of firms including the Coventry Building Society and Petronas.
File results
-
FOI/2022/0388 - Contact details for Medical Device Manager
-
FOI/2022/0389 - Facilities available for non-consultant grade doctors
-
FOI/2022/0391 - Research into Covid-19 loss of smell and taste
-
FOI/2022/0405 - Treatments C1-esterase inhibitor & immunoglobulin treatments
-
FOI/2022/0407 - Rooftop and greenfield mobile mast site agreements
-
FOI/2022/0411 - Resident Medical Officers/ Resident Doctors/ Senior House Officers supplied by agencies
-
FOI/2022/0421 - Paediatric autoimmune neuropsychiatric disorders
-
FOI/2022/0422 - Annual salary directors
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0465 - Treatment of dermatological conditions